Ipsen appoints new board director

Coiled Therapeutics completes enrolment in two AO-252 formulation cohorts

MaaT Pharma outlines potential Phase 3 development plan for MaaT013 after CHMP negative opinion

Kemp Proteins partners with NeuImmune to advance precision protein production

Genentech's Lunsumio regimen improves progression-free survival in Phase III follicular lymphoma study

Bayer's Kerendia wins FDA approval for chronic kidney disease associated with type 1 diabetes

ProBio and Kun Tuo collaborate to deliver integrated CDMO-CRO solutions for advanced therapies

Myosin Therapeutics chosen for 2026-2027 NCI Investor Initiatives Showcase

Sobi and Innate confirm strategic partnership

Viatris receives Japanese approval for WAKIX in narcolepsy and sleep apnoea

WHO identifies SynAct Pharma's resomelagon among six dengue drug candidates

Japan approves subcutaneous Leqembi formulation for early Alzheimer's disease

Japan approves Lundbeck's eptinezumab for preventive migraine treatment

Jubilant Therapeutics reports preliminary clinical data from Phase 1/2 study in myeloproliferative neoplasms at SOHO 2026

Skyhawk Therapeutics reports final results from Phase 1/2 trial in Huntington's disease